Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation

Shweta Mishra, Ekta Verma, Shailendra Patil, Dhanji P. Rajani, Asmita Gajbhiye

Open source

DOI
10.1016/j.rechem.2023.101253
Published
2024-01
Container
Results in Chemistry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rechem.2023.101253,
  title = {Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation},
  author = {Shweta Mishra and Ekta Verma and Shailendra Patil and Dhanji P. Rajani and Asmita Gajbhiye},
  year = {2024},
  journal = {Results in Chemistry},
  doi = {10.1016/j.rechem.2023.101253},
  url = {https://doi.org/10.1016/j.rechem.2023.101253}
}

RIS

TY  - JOUR
TI  - Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation
AU  - Shweta Mishra
AU  - Ekta Verma
AU  - Shailendra Patil
AU  - Dhanji P. Rajani
AU  - Asmita Gajbhiye
PY  - 2024
JO  - Results in Chemistry
DO  - 10.1016/j.rechem.2023.101253
UR  - https://doi.org/10.1016/j.rechem.2023.101253
ER  - 

APA

Mishra, S., Verma, E., Patil, S., Rajani, D. P., & Gajbhiye, A. (2024). Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation. Results in Chemistry. https://doi.org/10.1016/j.rechem.2023.101253

Source records